Search Results - "Weel, Angelique E"

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial by van Mulligen, Elise, Weel, Angelique E, Hazes, J M, van der Helm-van Mil, Annette, de Jong, Pascal Hendrik Pieter

“…To evaluate the 2-year clinical effectiveness of two gradual tapering strategies. The first strategy consisted of tapering the conventional synthetic…”
Get more information

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis by de Rotte, Maurits C F J, Pluijm, Saskia M F, de Jong, Pascal H P, Bulatović Ćalasan, Maja, Wulffraat, Nico M, Weel, Angelique E A M, Lindemans, Jan, Hazes, J M W, de Jonge, Robert

“…The objective was to predict insufficient response to 3 months methotrexate (MTX) in DMARD naïve rheumatoid arthritis patients. A Multivariable logistic…”
Get full text

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial by van Mulligen, Elise, Weel, Angelique E, Kuijper, Tjallingius Martijn, Denissen, N H A M, Gerards, Andreas H, de Jager, Mike H, Lam-Tse, Wai-Kwan, Hazes, J M, van der Helm-van Mil, Annette, de Jong, Pascal Hendrik Pieter, Luime, Jolanda J

“…The aim of the current study was to evaluate the 2-year cost-utility ratio between tapering conventional synthetic disease-modifying antirheumatic drugs…”
Get more information

Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study by van Veghel, Willem, van Dijk, Suzanne C, Klem, Taco MAL, Weel, Angelique E, Bügel, Jean-Bart, Birnie, Erwin

“…ObjectivesThe objective is to develop a pragmatic framework, based on value-based healthcare principles, to monitor health outcomes per unit costs on an…”
Get full text

The IMPACT study: A clustered randomized controlled trial to assess the effect of a referral algorithm for axial spondyloarthritis by Jamal, Maha, Korver, Amber M, Kuijper, Martijn, Lopes Barreto, Deirisa, Appels, Cathelijne W Y, Spoorenberg, Anneke P L, Koes, Bart W, Hazes, Johanna M W, Hoeven, Lonneke van, Weel, Angelique E A M

“…A substantial number of patients with chronic low back pain (CLBP) have axial spondyloarthritis (axSpA), but early recognition of these patients is difficult…”
Get full text

Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain by van Hoeven, Lonneke, Boonen, Annelies E R C H, Hazes, Johanna M W, Weel, Angelique E A M

“…To understand the impact of yet undiagnosed non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) on work outcomes in a cohort of…”
Get full text

The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis by Karreman, Maren C, Luime, Jolanda J, Hazes, Johanna M W, Weel, Angelique E A M

“…Inflammatory bowel disease [IBD] is a chronic disease which affects up to 0.5% of the population. Various extraintestinal manifestations occur, among which are…”
Get full text

External Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain by van Hoeven, Lonneke, Vergouwe, Yvonne, de Buck, P D M, Luime, Jolanda J, Hazes, Johanna M W, Weel, Angelique E A M

“…To validate and optimize a referral rule to identify primary care patients with chronic low back pain (CLBP) suspected for axial spondyloarthritis (axSpA)…”
Get full text

Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands by van Mulligen, Elise, Ahmed, Saad, Weel, Angelique E. A. M., Hazes, Johanna M. W., van der Helm- van Mil, Annette H. M., de Jong, Pascal H. P.

“…We aim to explore real-world biological survival stratified for discontinuation reason and determine its influenceability in rheumatoid arthritis (RA)…”
Get full text

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study by van Mulligen, Elise, de Jong, Pascal Hendrik Pieter, Kuijper, Tjallingius Martijn, van der Ven, Myrthe, Appels, Cathelijne, Bijkerk, Casper, Harbers, Joop B, de Man, Yael, Molenaar, T H Esmeralda, Tchetverikov, Ilja, Goekoop-Ruiterman, Yvonne P M, van Zeben, Jende, Hazes, Johanna M W, Weel, Angelique E A M, Luime, Jolanda J

“…The aim of this study is to evaluate the effectiveness of two tapering strategies after achieving controlled disease in patients with rheumatoid arthritis…”
Get more information

Progression From Subclinical Inflammation to Overt Spondyloarthritis in First‐Degree Relatives of Patients in Association With HLA–B27: The Pre‐Spondyloarthritis Cohort by Jong, Henriëtte M. Y., Winter, Janneke J. H., Horst‐Bruinsma, Irene E., Schaardenburg, Dirk‐Jan, Gaalen, Floris A., Tubergen, Astrid M., Weel, Angelique E. A. M., Landewé, Robert B. M., Baeten, Dominique L. P., Sande, Marleen G. H.

“…Objective As first‐degree relatives (FDRs) of HLA–B27–positive patients with axial spondyloarthritis (SpA) have an increased risk of developing axial SpA, the…”
Get full text

Hydroxychloroquine affects bone resorption both in vitro and in vivo by Both, Tim, Zillikens, M. Carola, Schreuders‐Koedam, Marijke, Vis, Marijn, Lam, Wai‐Kwan, Weel, Angelique E. A. M., van Leeuwen, Johannes P. T. M., van Hagen, P. Martin, van der Eerden, Bram C. J., van Daele, Paul L. A.

“…We recently showed that patients with primary Sjögren syndrome (pSS) have significantly higher bone mineral density (BMD) compared to healthy controls. The…”
Get full text

Study protocol for a cluster randomized controlled trial to evaluate a referral strategy for axial spondyloarthritis in young primary care patients with chronic low back pain; an impact study by van Hoeven, Lonneke, Vergouwe, Yvonne, Koes, Bart W, Hazes, Johanna M W, Weel, Angelique E A M

“…Axial spondyloarthritis (axSpA) is a disabling inflammatory joint disease with chronic low back pain (CLBP) as leading symptom. Recognizing axSpA in the large…”
Get full text

The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis by Karreman, Maren C, Luime, Jolanda J, Hazes, Johanna M W, Weel, Angelique E A M

“…Inflammatory bowel disease [IBD] is a chronic disease which affects up to 0.5% of the population. Various extraintestinal manifestations occur, among which are…”
Get full text

Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison by Koster, Fiona, Bakx, Pieter L. H., Kok, Marc R., Barreto, Deirisa Lopes, Weel-Koenders, Angelique E. A. M.

“…The prevalence of multimorbidity among rheumatoid arthritis (RA) patients is increasing and associated with worse outcomes. Therefore, management of…”
Get full text

Defining the care delivery value chain and mapping the patient journey in rheumatoid arthritis by Koster, Fiona, Lopes Barreto, Deirisa, Nair, Sandhya C., Kok, Marc R., Weel-Koenders, Angelique E. A. M.

“…Rheumatoid Arthritis (RA) is a chronic disease that impacts patients’ quality of life. Sophisticated organization of care delivery drives quality improvement…”
Get full text

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases by Engelhard, Esther A.N, Smit, Colette, van Dijk, Peter R, Kuijper, T Martijn, Wermeling, Paulien R, Weel, Angelique E, de Boer, Michiel R, Brinkman, Kees, Geerlings, Suzanne E, Nieuwkerk, Pythia T

“…OBJECTIVES:The health-related quality of life (HRQOL) of people with HIV is lower than in the general population, but it is unknown how it compares with that…”
Get full text

Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria by DE JONG, Pascal H. P, HAZES, Johanna M. W, ZEBEN, Derkjen Van, DER LUBBE, Peter A. Van, DE JAGER, Mike H, DE SONNAVILLE, Peter B, LUIME, Jolanda J, WEEL, Angelique E. A. M

“…To evaluate the therapeutic and economic consequences of various disease activity indices (DAIs) in RA according to 1987 and 2010 criteria. Data on disease…”
Get full text

Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing by Koster, Fiona, Kok, Marc R., van der Kooij, Jaco, Waverijn, Geeke, Weel-Koenders, Angelique E. A. M., Barreto, Deirisa Lopes

“…Background Time-driven activity-based costing (TDABC) can support value-based healthcare (VBHC) programs by providing insights into the actual relationships…”
Get full text

Impact of musculoskeletal joint complaints on quality of life in patients with inflammatory bowel disease: a cross-sectional study by Jamal, Maha, Karreman, Maren, de Bruijne, Frederieke, Kuijper, T. Martijn, Hazes, J M, Lopes Barreto, Deirisa, Weel, Angelique E

“…Background Musculoskeletal joint complaints (MSCs) are the most common extraintestinal manifestation of inflammatory bowel disease (IBD). We aimed to…”
Get full text